VVY — Vivoryon Therapeutics NV Cashflow Statement
0.000.00%
Last trade - 00:00
- €11.76m
- -€30.44m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.74 | -7.82 | -16.5 | -12.2 | -28.2 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.075 | 0.072 | 0.653 | 1.37 | 6.19 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.645 | -3.94 | 1.7 | -0.565 | 0.211 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6.99 | -11.6 | -14 | -11.3 | -21.8 |
Capital Expenditures | -0.016 | -0.047 | -0.064 | -0.028 | -0.013 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.476 | 0 | -0.576 | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.46 | -0.047 | -0.64 | -0.028 | -0.013 |
Financing Cash Flow Items | — | -1.83 | 0 | -1.88 | -2.53 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 49.4 | -0.09 | -0.827 | 33.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6.51 | 37.7 | -15.2 | -11.6 | 11.9 |